Antibody treatment of ulcerative colitis - ScienceDirect
Mechanism of Action | Entyvio® (vedolizumab)
Vedolizumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
Ulcerative Colitis - Gastrointestinal Disorders - Merck Manuals Professional Edition
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology
Interrogating host immunity to predict treatment response in inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
Mechanism of Action | Entyvio® (vedolizumab)
Vedolizumab Overview - Creative Biolabs
Mechanism of vedolizumab. This image is modified from their original... | Download Scientific Diagram
A mechanism of action of vedolizumab. | Download Scientific Diagram
Tofacitinib in ulcerative colitis | Immunotherapy
Classes of Biologics for the Treatment of IBD - ALPCO
Figure 7 | Lung and Intestine: A Specific Link in an Ulcerative Colitis Rat Model
Ulcerative colitis - The Lancet
STELARA® (ustekinumab) Mechanism of Action: Plaque Psoriasis
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program | SpringerLink
View of IMPORTANCE OF NANOCARRIERS AND PROBIOTICS IN THE TREATMENT OF ULCERATIVE COLITIS | International Journal of Applied Pharmaceutics
Ulcerative colitis: an update | RCP Journals
Vedolizumab | New Drug Approvals
Ulcerative colitis | Nature Reviews Disease Primers
Promising biological therapies for ulcerative colitis: A review of the literature
